Dedicated Robotic-Assisted Microsurgery Platforms in Plastic and Reconstructive Surgery: A Systematic Review.

MicrosurgerySep 1, 2026
Clinical ResearchPlastic SurgeryOpen access

Simon M Kratzer, Mehmet Ergisi, Laura Awad et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review evaluated dedicated robotic-assisted microsurgery platforms in plastic and reconstructive surgery, analyzing 21 studies published from 2015 to 2025. The review found that free flap survival rates were high at 96%-100%, and robotic anastomosis times decreased by 51%-66% with experience, although they remained longer than manual benchmarks.

Key findings

  • Free flap reconstruction survival rates ranged from 96% to 100%.
  • Anastomotic patency for supermicrosurgery was reported at 96.6% to 100%.
  • Robotic anastomosis times decreased by 51%-66% with increased experience.
  • Conversion or failure rates were low, ranging from 0% to 4.3%.

Why it matters

Understanding the effectiveness and safety of robotic-assisted microsurgery can help clinicians make informed decisions about adopting these technologies in practice, particularly in complex reconstructive procedures.

Source

PubMed · PMID 42661276Free full text on PubMed Central

Published in Microsurgery. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Plastic Surgery

Clinical ResearchOncology (Medical)

Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.

This phase 3 randomized clinical trial evaluated the efficacy and safety of osimertinib combined with chemotherapy versus osimertinib alone in 294 patients with advanced non-small cell lung cancer (NSCLC) harboring…

JAMASep 8, 2026Open accessRead summary
Clinical ResearchHematology

Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.

This phase 2 randomized trial compared azacitidine plus venetoclax to induction chemotherapy in 172 previously untreated adults with acute myeloid leukemia (AML) eligible for induction.

N Engl J MedSep 3, 2026Read summary
Clinical ResearchPsychiatry

The efficacy of modified psychodynamic psychotherapy for patients with schizophrenia-spectrum disorders in Germany: a prospective, single-centre, assessor-blinded, parallel-group, randomised controlled trial.

This randomized controlled trial evaluated the efficacy of Modified Psychodynamic Psychotherapy for Schizophrenia (MPP-S) combined with treatment as usual (TAU) in 130 outpatients with schizophrenia-spectrum disorders…

Lancet PsychiatrySep 10, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.